Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: A population-based cohort study among British women

Cancer Causes and Control

Volumn 23, Issue 11, 2012, Pages 1785-1795

  Redaniel, Maria Theresa M ^a   Jeffreys, Mona ^a   May, Margaret T ^a   Ben Shlomo, Yoav ^a   Martin, Richard M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Breast cancer risk; British women; Diabetes; Diabetes treatment; GPRD

Indexed keywords

ALCOHOL; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SMOKING; UNITED KINGDOM;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; INSULIN; META-ANALYSIS AS TOPIC; METFORMIN; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84867998462     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0057-0     Document Type: Article

References (41)

1. Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:s823-s835
2. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856-862 (Pubitemid 47106217)
3. Kabat GC et al (2009) Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125:2704-2710
4. Lawlor DA, Davey Smith G, Ebrahim S (2004) Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15:267-275 (Pubitemid 38988035)
5. Rapp K et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49: 945-952
6. Partanen L et al. (2012) Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer. Genes Chromosom Cancer 51:832-840
7. Smith U, Gale EA (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52:1699-1708
8. Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114:63-70 (Pubitemid 351998745)
9. LeRoith D (2010) Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models. Diabetes Metab Res Rev 26:599-601
10. Colhoun HM (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755-1765
11. Jonasson JM et al (2009) Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia 52:1745-1754
12. Hemkens LG et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52:1732-1744
13. Pollak M (2010) Metformin and other biguanides in oncology: advancing the research agenda. Cancer Prev Res (Phila) 3: 1060-1065
14. Schimmack G, Defronzo RA, Musi N (2006) AMP-activated protein kinase: role in metabolism and therapeutic implications. Diabetes Obes Metab 8:591-602 (Pubitemid 44515556)
15. Bodmer M et al. (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33:1304-1308
16. Libby G et al (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620-1625
17. Bosco JL et al (2011) Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 20:101-111
18. Currie CJ, Poole CD, Gale EA (2009) The influence of glucoselowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766-1777
19. van Staa TP et al (2012) Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia 55:654-665
20. Andersson C et al. (2012) Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people. BMJ Open 2. doi:10.1136/bmjopen-2011-000433
21. Cannata D et al (2010) Type 2 diabetes and cancer: what is the connection? Mt Sinai J Med 77:197-213
22. Peairs KS et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29: 40-46
23. Currie CJ et al (2012) Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 35:299-304
24. Liu X et al (2012) The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer 118:1353-1361
25. Dregan A et al. (2012) Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. Cancer Epidemiol. doi: 10.1016/j.canep.2012.05.013
26. Office for National Statistics (2000) Key health statistics from general practice 1998. Series MB6 no.2, ONS, Editor, London
27. Herrett E et al (2010) Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69:4-14
28. Khan NF, Harrison SE, Rose PW (2010) Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 60:e128-e136
29. Kaye JA et al (2000) The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer 83:1556-1558
30. General Practice Research Database (2010) The General Practice Research Database. Last updated: 2010 (Cited: April 10, 2010). Available from: http://www.gprd.com/home/
31. Cooper R et al (2008) Menopausal status and physical performance in midlife: findings from a British birth cohort study. Menopause 15:1079-1085
32. Office of the Deputy Prime Minister (2004) The English indices of deprivation 2004: summary. Office of the Deputy Prime Minister, London
33. Royston P (2005) Multiple imputation of missing values: update office. Stata J 5:527-536 (Pubitemid 43708457)
34. Sterne JA et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393
35. Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219 (Pubitemid 36143396)
36. Levesque LE et al (2010) Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 340:b5087
37. StataCorp (2012) Stata/MP 12.1 for Windows. StataCorp LP, College Station, TX
38. Lipscombe LL et al (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98:349-356 (Pubitemid 44195606)
39. Michels KB et al (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26:1752-1758 (Pubitemid 36929115)
40. Wolf I et al (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103-111 (Pubitemid 40197704)
41. Suissa S et al (2011) Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia 54:2254-2262